Binding proteins specific for insulin-like growth factors and uses thereof
Details for Australian Patent Application No. 2006326649 (hide)
International Classifications
Event Publications
26 June 2008 PCT application entered the National Phase
PCT publication WO2007/070432 Priority application(s): WO2007/070432
14 August 2008 Alteration of Name
The name of the applicant has been altered to AstraZeneca AB
24 March 2011 Application Accepted
Published as AU-B-2006326649
21 July 2011 Standard Patent Sealed
20 October 2011 Assignment Registered
AstraZeneca AB The patent has been assigned to MedImmune Limited
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser